Matthew Ferrari

Director of the Center for Infectious Disease Dynamics; Huck Career Development Professor; Professor of Biology

Matthew Ferrari

Research Summary

Public Health, Quantitative Epidemiology, Population Ecology, Statistics, Computational and Mathematical Biology

Huck Affiliations

Links

Publication Tags

Vaccination Measles Disease Outbreaks Population Antibodies Pandemics Health Sars Virus Viruses Vaccines Testing Public Health Neutralizing Antibodies Epidemiology Uncertainty Students Infections Decision Making Liberia Simulation Learning Immunotherapy Immunity Epidemics Incidence

Most Recent Papers

Differential health impact of intervention programs for time-varying disease risk

Allison Portnoy, Yuli Lily Hsieh, Kaja Abbas, Petra Klepac, Heather Santos, Logan Brenzel, Mark Jit, Matthew Ferrari, 2022, BMC Medicine

Large university with high COVID-19 incidence is not associated with excess cases in non-student population

Nita Bharti, Brian Lambert, Cara Exten, Christina Faust, Matthew Joseph Ferrari, Anthony Robinson, 2022, Scientific Reports

COVID-19 Mitigation Among College Students

Rachel A. Smith, Meg L. Small, Nita Bharti, Samuel J. DeMatte, Robert P. Lennon, Matthew Joseph Ferrari, 2022, Health Communication

Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy

Abhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, Meera Surendran Nair, Ruth H. Nissly, Denver Greenawalt, Ian M. Bird, Catherine M. Herzog, Matthew J. Ferrari, Indira Poojary, Robab Katani, Scott E. Lindner, Allen M. Minns, Randall Rossi, Paul A. Christensen, Brian Castillo, Jian Chen, Todd N. Eagar, Xin Yi, Picheng Zhao, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, Suresh V. Kuchipudi, James M. Musser, Vivek Kapur, 2021, Communications Biology

Vaccination strategies for measles control and elimination

F. T. Cutts, M. J. Ferrari, L. K. Krause, A. J. Tatem, J. F. Mosser, 2021, BMC Medicine

The Effects of Using a Clinical Prediction Rule to Prioritize Diagnostic Testing on Transmission and Hospital Burden

Jody R. Reimer, Sharia M. Ahmed, Ben J. Brintz, Rashmee U. Shah, Lindsay T. Keegan, Matthew J. Ferrari, Daniel T. Leung, 2021, Clinical Infectious Diseases on p. 1822-1830

Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing.

E Howerton, M Ferrari, O Bjørnstad, T Bogich, R Borchering, C Jewell, J Nichols, Probert WJM, M Runge, M Tildesley, C Viboud, K Shea, 2021, PLoS Computational Biology on p. e1009518

Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response

James M. Azam, Barbara Saitta, Kimberly Bonner, Matthew J. Ferrari, Juliet R.C. Pulliam, 2021, Vaccine on p. 5845-5853

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-covid-19 world

Jaspreet Toor, Susy Echeverria-Londono, Xiang Li, Kaja Abbas, Emily D. Carter, Hannah E. Clapham, Andrew Clark, Margaret J. de Villiers, Kirsten Eilertson, Matthew Ferrari, Ivane Gamkrelidze, Timothy B. Hallett, Wes R. Hinsley, Daniel Hogan, John H. Huber, Michael L. Jackson, Kevin Jean, Mark Jit, Andromachi Karachaliou, Petra Klepac, Alicia Kraay, Justin Lessler, Xi Li, Benjamin A. Lopman, Tewodaj Mengistu, C. Jessica E. Metcalf, Sean M. Moore, Shevanthi Nayagam, Timos Papadopoulos, T. Alex Perkins, Allison Portnoy, Homie Razavi, Devin Razavi-Shearer, Stephen Resch, Colin Sanderson, Steven Sweet, Yvonne Tam, Hira Tanvir, Quan Tran Minh, Caroline L. Trotter, Shaun A. Truelove, Emilia Vynnycky, Neff Walker, Amy Winter, Kim Woodruff, Neil M. Ferguson, Katy A.M. Gaythorpe, 2021, eLife

Impact of covid-19-related disruptions to measles, meningococcal a, and yellow fever vaccination in 10 countries

Katy Gaythorpe, Kaja Abbas, John Huber, Andromachi Karachaliou, Niket Thakkar, Kim Woodruff, Xiang Li, Susy Echeverria-Londono, Matthew Ferrari, Michael L. Jackson, Kevin McCarthy, Alex Perkins, Caroline Trotter, Mark Jit, 2021, eLife

Most-Cited Papers

Assessment of the 2010 global measles mortality reduction goal

Emily Simons, Matthew Ferrari, John Fricks, Kathleen Wannemuehler, Abhijeet Anand, Anthony Burton, Peter Strebel, 2012, The Lancet on p. 2173--2178

Reduced vaccination and the risk of measles and other childhood infections post-Ebola

Saki Takahashi, C. Jessica E. Metcalf, Matthew J. Ferrari, William J. Moss, Shaun A. Truelove, Andrew J. Tatem, Bryan T. Grenfell, Justin Lessler, 2015, Science on p. 1240--1242

Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

James C. Glasbey, Dmitri Nepogodiev, Joana F.F. Simoes, Omar Omar, Elizabeth Li, Mary L. Venn, Mohammad K.Abou Chaar, Vita Capizzi, Daoud Chaudhry, Anant Desai, Jonathan G. Edwards, Jonathan P. Evans, Marco Fiore, Jose Flavio Videria, Samuel J. Ford, Ian Ganly, Ewen A. Griffiths, Rohan R. Gujjuri, Angelos G. Kolias, Haytham M.A. Kaafarani, Ana Minaya-Bravo, Siobhan C. McKay, Helen M. Mohan, Keith J. Roberts, Carlos San Miguel-Méndez, Peter Pockney, Richard Shaw, Neil J. Smart, Grant D. Stewart, Sudha Sundar, Raghavan Vidya, Aneel A. Bhangu, C. Allemand, L. Boccalatte, M. Figari, M. Lamm, J. Larrañaga, C. Marchitelli, F. Noll, D. Odetto, M. Perrotta, J. Saadi, L. Zamora, C. Alurralde, E. L. Caram, D. Eskinazi, J. P. Mendoza, M. Usandivaras, R. Badra, A. Esteban, 2021, Journal of Clinical Oncology on p. 66-78

Serology for SARS-CoV-2

Juliet E. Bryant, Andrew S. Azman, Matthew J. Ferrari, Benjamin F. Arnold, Maciej F. Boni, Yap Boum, Kyla Hayford, Francisco J. Luquero, Michael J. Mina, Isabel Rodriguez-Barraquer, Joseph T. Wu, Djibril Wade, Guy Vernet, Daniel T. Leung, 2020, Science immunology

Adaptive Management and the Value of Information

Katriona Shea, Michael J. Tildesley, Michael C. Runge, Christopher J. Fonnesbeck, Matthew J. Ferrari, 2014, PLoS Biology on p. e1001970

Understanding Herd Immunity

C. J.E. Metcalf, M. Ferrari, A. L. Graham, B. T. Grenfell, 2015, Trends in Immunology on p. 753-755

Impacto económico estimado de las vacunas en 73 países con ingresos bajos y medios, 2001-2020

Sachiko Ozawa, Samantha Clark, Allison Portnoy, Simrun Grewal, Meghan L. Stack, Anushua Sinha, Andrew Mirelman, Heather Franklin, Ingrid K. Friberg, Yvonne Tam, Neff Walker, Andrew Clark, Matthew Ferrari, Chutima Suraratdecha, Steven Sweet, Sue J. Goldie, Tini Garske, Michelle Li, Peter M. Hansen, Hope L. Johnson, Damian Walker, 2017, Bulletin of the World Health Organization on p. 629-638

Opinion

Eric T. Lofgren, M. Elizabeth Halloran, Caitlin M. Rivers, John M. Drake, Travis C. Porco, Bryan Lewis, Wan Yang, Alessandro Vespignani, Jeffrey Shaman, Joseph N.S. Eisenberg, Marisa C. Eisenberg, Madhav Marathe, Samuel V. Scarpino, Kathleen A. Alexander, Rafael Meza, Matthew J. Ferrari, James M. Hyman, Lauren A. Meyers, Stephen Eubank, 2014, Proceedings of the National Academy of Sciences of the United States of America on p. 18095-18096

Ebola Cases and Health System Demand in Liberia

John M. Drake, Raj Reni B. Kaul, Laura W. Alexander, Suzanne M. O’Regan, Andrew M. Kramer, J. Tomlin Pulliam, Matthew J. Ferrari, Andrew W. Park, 2015, PLoS Biology on p. e1002056

Decision-making for foot-and-mouth disease control: Objectives matter

William J.M. Probert, Katriona Shea, Christopher J. Fonnesbeck, Michael C. Runge, Tim E. Carpenter, Salome Dürr, M. Graeme Garner, Neil Harvey, Mark A. Stevenson, Colleen T. Webb, Marleen Werkman, Michael J. Tildesley, Matthew J. Ferrari, 2016, Epidemics on p. 10-19

News Articles Featuring Matthew Ferrari

Take Note: Penn State infectious disease expert Matthew Ferrari on the COVID-19 pandemic in 2022

COVID-19 cases are climbing again in Pennsylvania and nationally. And so are hospitalizations. Matthew Ferrari, director of Penn State’s Center for Infectious Disease Dynamics, is also part of the research project Data4Action, which has been measuring the impact of the pandemic on the local community for the last two years. WPSU's Anne Danahy spoke with Ferrari about the current upswing in COVID cases, how to understand the data and steps that can be taken in response.

Rise in COVID cases abroad, presence of omicron subvariant may foreshadow increase in US: Experts

Wastewater data in the U.S. indicates the beginnings of a potential resurgence.

Rise in COVID-19 infections overseas may foreshadow increase in US, experts say

When the coronavirus receded across much of the globe last month and the omicron surge declined, many Americans were hopeful that was perhaps the signal that the United States was entering a new phase of the pandemic.

What’s the true covid death toll in Pa.? New analysis sheds light

For many reasons, it’s hard to know the full impact of the covid-19 pandemic. Some deaths may have gone uncounted for reasons such as the person died at home and was never tested. A person may have died from an existing disease exacerbated by covid-19. Or a person may have died from a more indirect result of the pandemic, such as disruption in drug treatment that led to overdose.

How Centre County school districts are adapting as omicron challenges in-person learning

Unlike last school year, Centre County school districts have avoided a shift to remote learning, and despite the rise of COVID-19 cases, they plan to keep it that way.

Europe gives US gloomy portrait of what's to come with omicron

As the omicron variant batters Europe with exponentially skyrocketing COVID-19 cases, public health experts warn that the U.S. could be barreling down the same path and face record waves of infections in the coming days and weeks.

What omicron's fast spread could mean for the U.S. – and the world

The first country to really get hit by omicron is South Africa. Before the new variant took off last month, coronavirus cases there were low – only several hundred per day in mid November. But by early December, the tally of daily infections had shot up to more than 4,500 — and genomic sequencing shows that omicron is to blame.

Should I be worried about the new omicron coronavirus variant?

The omicron variant (B.1.1.529) of SARS-CoV-2, which has now been detected in the U.S., has been listed as a "variant of concern" by the World Health Organization, which has stated that the overall global risk related to the variant is "very high."

The Omicron Variant Is a Mystery. Here’s How Science Will Solve It

So far, panic about the new Covid variant has outpaced actual information. Here’s what scientists around the world are trying to uncover.

End of COVID-19 crisis stage — fingers crossed — might be near

The end of the high-alert, constant worry over COVID-19 might be near — possibly as soon as early next year. We still need to be smart and careful. We must solve a few problems. We also need some good luck.